Locations:
SearchFunding from Clorox will be used to explore research, advance training and education, launch healthcare innovations
images: 0
video: 0
audio: 0
text: 0
Throughout the COVID-19 pandemic, Cleveland Clinic and The Clorox Company have collaborated on health and safety measures to limit the spread of the virus in everyday life and in the workplace. Now, the two organizations are taking this commitment a step further by establishing the Clorox Public Health Research Fund. Bolstered by a $1 million donation from Clorox, the fund will further Cleveland Clinic’s exploration of innovative research ideas, advance new training and education opportunities, and launch promising healthcare innovations.
Rooted in Cleveland Clinic’s 100 years of medical discovery and Clorox’s century-long legacy in health and wellness, the goals of the Clorox Public Health Research Fund include initiating promising health technology, investigating new research approaches, and designing healthcare solutions. Initially, the organizations will prioritize research and discovery focused on the COVID-19 virus.
Research supported by the fund will inform the development of tomorrow’s virus-fighting cleaners and other health and safety products, along with practices and protocols.
“Research to better understand this pandemic is vitally important and where immediate funding makes a critical difference,” said Serpil Erzurum, M.D., Chief Research and Academic Officer at Cleveland Clinic. “Funds from Clorox will allow us to accomplish more and have a broader, meaningful impact on discovery and innovations for COVID-19 and for many other future public health threats.”
“As a health and wellness company, we are proud to be extending our work with Cleveland Clinic in support of public health,” said Ed Huber, Vice President of Strategic Growth and Chief Sustainability Officer at The Clorox Company. “It’s important that we continue to advance research and develop science-based innovations with Cleveland Clinic to help fight COVID-19, and to help us be better prepared in the future.”
“We are grateful for Clorox’s support so that this new funding stream can be available to our scientists,” said Lara Kalafatis, Chair of Cleveland Clinic’s Philanthropy Institute. “We are excited to celebrate our centennial celebration with the important investment from Clorox, so our researchers can pursue the most promising ideas and innovations and fulfill our shared commitment to public health and wellness now and for the next 100 years.”
About Cleveland Clinic
Cleveland Clinic – now in its centennial year – is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 70,800 employees worldwide are more than 4,660 salaried physicians and researchers, and 18,500 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,500-bed health system that includes a 173-acre main campus near downtown Cleveland, 19 hospitals, more than 220 outpatient facilities, and locations in southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2020, there were 8.7 million total outpatient visits, 273,000 hospital admissions and observations, and 217,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
The Clorox Company
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags and wraps; Kingsford® grilling products; Hidden Valley® dressings and sauces; Brita® water-filtration products; Burt's Bees® natural personal care products; and RenewLife®, Rainbow Light®, Natural Vitality Calm™, NeoCell® and Stop Aging Now® vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names. More than 80% of the company’s sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories.
Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation’s New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, listed No. 1 on the 2020 Axios Harris Poll 100 reputation rankings and included on the Barron’s 2021 100 Most Sustainable Companies list, 2021 Bloomberg Gender-Equality Index and the Human Rights Campaign’s 2021 Corporate Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed more than $25 million in combined cash grants, product donations and cause marketing in fiscal year 2020. For more information, visit TheCloroxCompany.com, including the Good Growth blog, and follow the company on Twitter at @CloroxCo.
